List of Publications
(*: main author)

• * Advanced Materials (Accepted, IF=27.6) (*: co-first author)
  J. Choi*, J. Byun*, D. Kim, Q. Li, D. Jin, Y. Choi, H. Jung, J. Lee, Y.-K. Oh, Selective lipolysis by photoactivation of chaperone-mediated autophagy using adipocyte membrane-coated nanoparticle in hydrogel, Advanced Materials (Accepted). 

• * Journal of Controlled Release (Accepted, IF=10.5) (*: corresponding author)
  J. Choi, D. Jin, SC. De Smedt, Y.-K. Oh, J. Lee, J. Byun*, Targeted lipolysis for obesity treatment: Cold atmospheric plasma–responsive nanoparticles amplify reactive oxygen species generation in adipocytes, Journal of Controlled Release (Accepted)

• * Journal of Controlled Release (2025, IF=10.5) (*: corresponding author)
  D. Kim, J. Choi, D. Jin, E. Xu, J. Lee*, J. Byun*, Y.-K. Oh*, Hybrid lipid nanoparticles with tumor antigen-primed dendritic cell membranes for post-surgical tumor immunotherapy , Journal of Controlled Release (2025) 379, 537-548

• Nature Communications (2024, IF=14.7)
  Y. Wu, J. Park, Q-V. Le, J. Byun, J. Choi, E. Xu, J. Lee, Y-K. Oh, NET formation-mediated in situ protein delivery to the inflamed central nervous system, Nature Communications (2024), 15(1)

• * Asian J. Pharm. Sci (2024, IF=10.7)  (*: co-first author)
  Q. Li*, J. Byun*, D. Kim, Y. Wu, J. Lee, Y.-K. Oh, Cell membrane-coated mRNA nanoparticles for enhanced delivery to dendritic cells and immunotherapy, Asian Journal of Pharmaceutical Sciences (2024)

• * Advanced Drug Delivery Reviews (2024, IF=15.2) (*: corresponding author)
  J. Park, Y. Wu, JS. Kim, J. Byun*, J. Lee*, Y.-K. Oh*, Cytoskeleton-modulating nanomaterials and their therapeutic potentials, Advanced Drug Delivery Reviews (2024), 115362. 

• * ACS Nano (2024, IF=15.8) (*: co-first author)
  Q. Li*, J. Byun*, J. Choi, J. Park, J. Lee, Y.-K. Oh, Nanomodulator-Mediated Restructuring of Adipose Tissue Immune Microenvironments for Antiobesity Treatment, ACS Nano (2024).

• * The AAPS Journal (2023, IF=5) (*: co-first author)
  J. Byun*, Y. Wu*, J. Park*, JS. Kim, Q. Li, J. Choi, N. Shin, M. Lan, Y. Cai, J. Lee, Y.-K. Oh, RNA Nanomedicine: Delivery Strategies and Applications, The AAPS Journal 25 (2023) 95. 

• * Biomaterials (2023, IF=12.8) (*: first author)
  J. Byun*, Y. Wu, J. Lee, JS. Kim, G. Shim, Y.-K. Oh, External cold atmospheric plasma-responsive on-site hydrogel for remodeling tumor immune microenvironment, Biomaterials 299 (2023) 122162.

• Journal of Controlled Release (2022, IF=10.5)
  D. Kim, J. Byun, S. Kim, H. Chung, Y. Kim, G. Shim, Y.-K Oh, DNA-cloaked nanoparticles for tumor microenvironment-responsive activation, Journal of Controlled Release 350 (2022) 448-459

• Bioactive Materials (2022, IF=18.0)
  Q.-V. Le, J. Lee, J. Byun, G. Shim, Y.-K. Oh, DNA-based artificial dendritic cells for in situ cytotoxic t cell stimulation and immunotherapy, Bioactive Materials 15 (2022) 160-172.

• Advanced Drug Delivery Reviews (2022, IF=15.2)
  J. Lee, D. Kim, J. Byun, Y. Wu, J. Park, Y.-K. Oh, In vivo fate and intracellular trafficking of vaccine delivery systems, Advanced Drug Delivery Reviews 186 (2022) 114325

• * Nature Communications (2022, IF=14.7) (*: co-first author)
  J. Lee*, J. Byun*, G. Shim, Y.-K. Oh, Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis, Nature Communications 13 (2022) 1-16.

• Biomaterials (2022, IF=12.8)
  H. Park, D. Kim, B. Cho, J. Byun, Y.S. Kim, Y. Ahn, J. Hur, Y.-K. Oh, J. Kim, In vivo therapeutic genome editing via crispr/cas9 magnetoplexes for myocardial infarction, Biomaterials 281 (2022) 121327.

• Advanced Materials (2021, IF=27.4)
  M. Kang, S.H. Lee, M. Kwon, J. Byun, D. Kim, C. Kim, S. Koo, S.P. Kwon, S. Moon, M. Jung, Nanocomplex‐mediated in vivo programming to chimeric antigen receptor‐m1 macrophages for cancer therapy, Advanced Materials 33 (2021) 2103258.

• * Biomedicines (2020, IF=3.9) (*: co-first author)
  J. Byun*, D. Kim*, J. Choi, G. Shim, Y.-K. Oh, Photosensitizer-trapped gold nanocluster for dual light-responsive phototherapy, Biomedicines 8 (2020) 521. 

• Journal of Controlled Release (2020, IF=10.5)
  J.-B. Qiao, Q.-Q. Fan, C.-L. Zhang, J. Lee, J. Byun, L. Xing, X.-D. Gao, Y.-K. Oh, H.-L. Jiang, Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis, Journal of Controlled Release 321 (2020) 629-640.

• * Book Chapter (2020)
  G. Shim, D. Kim, Q.-V. Le, J. Byun, J. Park, Y.-K. Oh, Biomaterials for gene editing, Biomaterials for Cancer Therapeutics: Evolution and Innovation (2020) 187.

• * Biomaterials Science (2020, IF=5.8) (*: co-first author)
  D. Kim*, J. Byun*, J. Park*, Y. Lee, G. Shim, Y.-K. Oh, Biomimetic polymeric nanoparticle-based photodynamic immunotherapy and protection against tumor rechallenge, Biomaterials Science 8 (2020) 1106-1116.

• Nanomedicine: Nanotechnology, Biology and Medicine (2019, IF=4.2)
  G. Shim, D. Kim, S. Lee, R.S. Chang, J. Byun, Y.-K. Oh, Staphylococcus aureus-mimetic control of antibody orientation on nanoparticles, Nanomedicine: Nanotechnology, Biology and Medicine 16 (2019) 267-277.

JCR 2023 Impact Factor (updated 2024)